NSD1 inactivation defines an immune cold, DNA hypomethylated subtype in squamous cell carcinoma

[1]  Petar Stojanov,et al.  Integrative and Comparative Genomic Analysis of HPV-Positive and HPV-Negative Head and Neck Squamous Cell Carcinomas , 2014, Clinical Cancer Research.

[2]  William T. Chiu,et al.  Genome-wide view of TGFβ/Foxh1 regulation of the early mesendoderm program , 2014, Development.

[3]  Ash A. Alizadeh,et al.  Abstract PR09: The prognostic landscape of genes and infiltrating immune cells across human cancers , 2015 .

[4]  Miguel Alaminos,et al.  Epigenetic inactivation of the Sotos overgrowth syndrome gene histone methyltransferase NSD1 in human neuroblastoma and glioma , 2009, Proceedings of the National Academy of Sciences.

[5]  T. Gajewski,et al.  Melanoma-intrinsic β-catenin signalling prevents anti-tumour immunity , 2015, Nature.

[6]  D. Reinberg,et al.  The Structure of NSD1 Reveals an Autoregulatory Mechanism Underlying Histone H3K36 Methylation* , 2010, The Journal of Biological Chemistry.

[7]  Benjamin J. Raphael,et al.  Multiplatform Analysis of 12 Cancer Types Reveals Molecular Classification within and across Tissues of Origin , 2014, Cell.

[8]  Steven J. M. Jones,et al.  Comprehensive molecular characterization of clear cell renal cell carcinoma , 2013, Nature.

[9]  Xiaohan Qu,et al.  PIWIL2 promotes progression of non-small cell lung cancer by inducing CDK2 and Cyclin A expression , 2015, Journal of Translational Medicine.

[10]  M. Scholz,et al.  The role of HPV RNA transcription, immune response‐related gene expression and disruptive TP53 mutations in diagnostic and prognostic profiling of head and neck cancer , 2015, International journal of cancer.

[11]  D. Weisenberger.  Characterizing DNA methylation alterations from The Cancer Genome Atlas. , 2014, The Journal of clinical investigation.

[12]  R. Tibshirani,et al.  Significance analysis of microarrays applied to the ionizing radiation response , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[13]  G. Getz,et al.  GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers , 2011, Genome Biology.

[14]  Rochelle L. Tiedemann,et al.  Dynamic reprogramming of DNA methylation in SETD2-deregulated renal cell carcinoma , 2015, Oncotarget.

[15]  G. Getz,et al.  Inferring tumour purity and stromal and immune cell admixture from expression data , 2013, Nature Communications.

[16]  Matteo Benelli,et al.  Divergent clonal evolution of castration resistant neuroendocrine prostate cancer , 2016, Nature Medicine.

[17]  Y. Hayashi,et al.  NUP98‐NSD1 gene fusion and its related gene expression signature are strongly associated with a poor prognosis in pediatric acute myeloid leukemia , 2013, Genes, chromosomes & cancer.

[18]  S Michiels,et al.  Tumor infiltrating lymphocytes are prognostic in triple negative breast cancer and predictive for trastuzumab benefit in early breast cancer: results from the FinHER trial. , 2014, Annals of oncology : official journal of the European Society for Medical Oncology.

[19]  Albert Jeltsch,et al.  The Dnmt3a PWWP Domain Reads Histone 3 Lysine 36 Trimethylation and Guides DNA Methylation* , 2010, The Journal of Biological Chemistry.

[20]  Cheng Li,et al.  Adjusting batch effects in microarray expression data using empirical Bayes methods. , 2007, Biostatistics.

[21]  S. Dow,et al.  Regulation of PD-L1 expression on murine tumor-associated monocytes and macrophages by locally produced TNF-α , 2017, Cancer Immunology, Immunotherapy.

[22]  Donald M. Bell,et al.  Tbx6-dependent Sox2 regulation determines neural vs mesodermal fate in axial stem cells , 2010, Nature.

[23]  Olivier Gevaert,et al.  MethylMix: an R package for identifying DNA methylation-driven genes , 2015, Bioinform..

[24]  T. Mikkelsen,et al.  Genome-scale DNA methylation maps of pluripotent and differentiated cells , 2008, Nature.

[25]  Lukas Burger,et al.  Genomic profiling of DNA methyltransferases reveals a role for DNMT3B in genic methylation , 2015, Nature.

[26]  H. Radzun,et al.  Stem-cell protein Piwil2 is widely expressed in tumors and inhibits apoptosis through activation of Stat3/Bcl-XL pathway. , 2006, Human molecular genetics.

[27]  Dylan M. Marchione,et al.  Impaired H3K36 methylation defines a subset of head and neck squamous cell carcinomas , 2017, Nature Genetics.

[28]  J. Lunceford,et al.  Safety and clinical activity of pembrolizumab for treatment of recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-012): an open-label, multicentre, phase 1b trial. , 2016, The Lancet. Oncology.

[29]  N. Rahman,et al.  NSD1 mutations are the major cause of Sotos syndrome and occur in some cases of Weaver syndrome but are rare in other overgrowth phenotypes. , 2003, American journal of human genetics.

[30]  A. Page,et al.  A transposon-based analysis of gene mutations related to skin cancer development. , 2013, The Journal of investigative dermatology.

[31]  P. Watson,et al.  CD20+ Tumor-Infiltrating Lymphocytes Have an Atypical CD27− Memory Phenotype and Together with CD8+ T Cells Promote Favorable Prognosis in Ovarian Cancer , 2012, Clinical Cancer Research.

[32]  Steven J. M. Jones,et al.  Comprehensive genomic characterization of squamous cell lung cancers , 2012, Nature.

[33]  R. Tibshirani,et al.  Pancancer analysis of DNA methylation-driven genes using MethylMix , 2015, Genome Biology.

[34]  Kathleen R. Cho,et al.  Epigenetic silencing of Th1 type chemokines shapes tumor immunity and immunotherapy , 2015, Nature.

[35]  L. Nardo,et al.  Tumor immune profiling predicts response to anti-PD-1 therapy in human melanoma. , 2016, The Journal of clinical investigation.

[36]  Christopher R. Cabanski,et al.  Molecular Subtypes in Head and Neck Cancer Exhibit Distinct Patterns of Chromosomal Gain and Loss of Canonical Cancer Genes , 2013, PloS one.

[37]  Steven J. M. Jones,et al.  Comprehensive molecular characterization of clear cell renal cell carcinoma , 2013, Nature.

[38]  E. Wagner,et al.  Understanding the language of Lys36 methylation at histone H3 , 2012, Nature Reviews Molecular Cell Biology.

[39]  N. Rahman,et al.  The NSD1 and EZH2 Overgrowth Genes, Similarities and Differences , 2013, American journal of medical genetics. Part C, Seminars in medical genetics.

[40]  Adelaide I J Young,et al.  ELF5 Drives Lung Metastasis in Luminal Breast Cancer through Recruitment of Gr1+ CD11b+ Myeloid-Derived Suppressor Cells , 2015, PLoS biology.

[41]  J. Rice,et al.  Role for the nuclear receptor-binding SET domain protein 1 (NSD1) methyltransferase in coordinating lysine 36 methylation at histone 3 with RNA polymerase II function , 2010, Proceedings of the National Academy of Sciences.

[42]  A. Gentles,et al.  Identification of an atypical etiological head and neck squamous carcinoma subtype featuring the CpG island methylator phenotype , 2017, EBioMedicine.

[43]  Steven A. Roberts,et al.  Mutational heterogeneity in cancer and the search for new cancer-associated genes , 2013 .

[44]  A. Loriot,et al.  A gene expression signature identifying transient DNMT1 depletion as a causal factor of cancer-germline gene activation in melanoma , 2015, Clinical Epigenetics.

[45]  Shihua Zhang,et al.  Tumor characterization and stratification by integrated molecular profiles reveals essential pan-cancer features , 2015, BMC Genomics.

[46]  A. Munnich,et al.  Paradoxical NSD1 mutations in Beckwith-Wiedemann syndrome and 11p15 anomalies in Sotos syndrome. , 2004, American journal of human genetics.

[47]  A. Loriot,et al.  Oncogenic roles of DNA hypomethylation through the activation of cancer-germline genes. , 2017, Cancer letters.

[48]  G. Núñez,et al.  IL-22 controls iron-dependent nutritional immunity against systemic bacterial infections , 2017, Science Immunology.

[49]  R. Tibshirani,et al.  Diagnosis of multiple cancer types by shrunken centroids of gene expression , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[50]  Steven J. M. Jones,et al.  Comprehensive genomic characterization of head and neck squamous cell carcinomas , 2015, Nature.

[51]  Joshua M. Korn,et al.  Integrated genotype calling and association analysis of SNPs, common copy number polymorphisms and rare CNVs , 2008, Nature Genetics.

[52]  Eric Bender,et al.  Big data in biomedicine , 2015, Nature.

[53]  Daniel M. Corey,et al.  PD-1 expression by tumor-associated macrophages inhibits phagocytosis and tumor immunity , 2017, Nature.

[54]  Peter A. Jones,et al.  Cancer genetics and epigenetics: two sides of the same coin? , 2012, Cancer cell.

[55]  Daria A. Gaykalova,et al.  Preferential Activation of the Hedgehog Pathway by Epigenetic Modulations in HPV Negative HNSCC Identified with Meta-Pathway Analysis , 2013, PloS one.

[56]  W. Reik,et al.  Epigenetic restriction of embryonic cell lineage fate by methylation of Elf5 , 2008, Nature Cell Biology.

[57]  Andrew P. Feinberg,et al.  Epigenetic modulators, modifiers and mediators in cancer aetiology and progression , 2016, Nature Reviews Genetics.

[58]  黒滝 直弘.  私の論文から Haploinsufficiency of NSD1 causes Sotos syndrome , 2003 .

[59]  A. Jemal,et al.  Cancer statistics, 2015 , 2015, CA: a cancer journal for clinicians.

[60]  P. Carpenter,et al.  An open and shut case for the role of NSD proteins as oncogenes , 2011, Transcription.

[61]  Peter Schirmacher,et al.  Tumor-infiltrating lymphocytes in colorectal tumors display a diversity of T cell receptor sequences that differ from the T cells in adjacent mucosal tissue , 2013, Cancer Immunology, Immunotherapy.

[62]  Adelaide I J Young,et al.  ELF5 Suppresses Estrogen Sensitivity and Underpins the Acquisition of Antiestrogen Resistance in Luminal Breast Cancer , 2012, PLoS biology.

[63]  谷口 智憲.  Immune suppression and resistance mediated by constitutive activation of Wnt/β-catenin signaling in human melanoma cells , 2013 .

[64]  A L Turinsky,et al.  NSD1 mutations generate a genome-wide DNA methylation signature , 2015, Nature Communications.

[65]  J. Wolchok,et al.  Toxicities of the anti-PD-1 and anti-PD-L1 immune checkpoint antibodies. , 2016, Annals of oncology : official journal of the European Society for Medical Oncology.

[66]  Ethan Cerami,et al.  Genomic analyses of gynaecologic carcinosarcomas reveal frequent mutations in chromatin remodelling genes , 2014, Nature Communications.

[67]  Axel Benner,et al.  Tumor-derived exosomes modulate PD-L1 expression in monocytes , 2017, Science Immunology.

[68]  M. Samur.  RTCGAToolbox: A New Tool for Exporting TCGA Firehose Data , 2014, PloS one.

[69]  Russ B. Altman,et al.  Missing value estimation methods for DNA microarrays , 2001, Bioinform..

[70]  Ash A. Alizadeh,et al.  Robust enumeration of cell subsets from tissue expression profiles , 2015, Nature Methods.

[71]  E. Tartour,et al.  Prognostic Value of Tumor-Infiltrating CD4+ T-Cell Subpopulations in Head and Neck Cancers , 2006, Clinical Cancer Research.

[72]  Patrice Ravel,et al.  PD-1-expressing tumor-infiltrating T cells are a favorable prognostic biomarker in HPV-associated head and neck cancer. , 2013, Cancer research.

[73]  Matthew D. Wilkerson,et al.  ConsensusClusterPlus: a class discovery tool with confidence assessments and item tracking , 2010, Bioinform..

[74]  R. Herbst,et al.  Clinical significance of PD-L1 protein expression on tumor-associated macrophages in lung cancer , 2015, Journal of Immunotherapy for Cancer.

[75]  J. Hengstler,et al.  Pathways of proliferation and antiapoptosis driven in breast cancer stem cells by stem cell protein piwil2. , 2010, Cancer research.